<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 124 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page123.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=124">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 124 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 124</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=124"><img src="../thumb/124.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.1.1 / 7.1.2 / 7.2                                    2020-04 / 93
       as digox.effs.enhanc.in these condits., pts.receiv.parathyr.extract./  weakn., alter.metabol.incl.gluc.metabol.disturbs., sweat., hypersali-  pertens., fatig., vertigo, headache, epididymo-orchit., impot., interstin.
       large Vit.D dos., monit.plasma lev.with concom.phenytoin/ pheno-  vat., headache, tiss.necros./ slough. with extravasat.  pneumonit., fibros., bronchosp., erythema dur.course of radio-ther., vas-
       barbit. or rifampic., lact.intol.  Special precautions: Prev.treatm., sev.ren.funct. impairm., cyclo-  culit., hyper/hypothyroidism., diffuse pulm. alveolit., hypersens.reacts.
       Drug interactions: Toxic.risk incr.by drugs. caus. electrol. disturbs.,   prane/halothane & other halogen. anaesth., reduc.urine flow without   Special precautions Thyroid funct.tests bef. start.& dur.ther.also
       plasma lev.poss.doubl.with quinidine, verapamil/nifedipine or ami-  hypotens.may indic. dos.reduct., grad.discont.avoid undue hypotens.   for some mnths.aft.discont. treatm.esp.in elderly, too high a dos.may
       odarone poss. incr.plasma conc., incr.card.arrhythm.risk with suxam-  assoc.with very low dos.where vasodilat. predomin, always infus.into   lead to sev.bradycard.& conduct.disturbs.with appear.of idioventric.
       ethon., bradycard.with beta-block.  large vein to avoid tiss.necros., check urine output freq.if dos.in ex-  rhythm partic.in elderly or dur.digit ther., exist.HF poss.worsen.by ther
                                     cess of 50 µg/kg/min.reqd., monit.BP & ren. funct. in life-threat.shock   latent/ manifest HF, dyspn.& non-product.cough onset poss. relat.to
                                     states, CV dis., arrhythm., tachycard., occlus.vasc.dis.incl. arterioscle-  pulmon.toxic., poss.overt liv.dis., risk of pro-arrhythm.effs.prolong.
       7.1.2  Others                 ros./ hypertens./aneurysm, ang.pain poss. precipit.in ang.pect.pts.  aft.meds stop.due to long eliminat.half-life, utilise.altern.agents
                                                                  first due to poss life-threat.probl., pts.to be hospitalis. while load.
              (See also 5.1)                                      dos.giv., pro-arrhythm.eff.usually occurs in combinat.with other pre-
                                                                  cipitat.fact.partic.other antiarrhytyhm. agents/digox.& hypokalaem.,
       AKRINOR, Adcock-Ingram Healthcare (Pty) Ltd  7.2  Anti-arrhythmics  plasma monit.of digox.recomm., freq.prothromb. monit.with concom.
       See Section 7.6                                            anticoags, strictly monit. combinat. ther.of ß-block.& cert.Ca chann.
                                     TAMBOCOR (MDR Listing)       inhibits., incr.risk of potent.lethal Torsade de Pointes with concom.
       DOBUTAMINE FRESENIUS 250 mg/20 ml, Fresenius Kabi          non-antiarrhythm agents, potent.sev. complicat.in pts.undergo. gen.
       [P/S]                         ADENOCOR, Sanofi-Aventis [P/S]  anaesth.eg. bradycard. unrespons.to atrop./hypotens./disturbs. of
       Dobutamine HCl                Adenosine                    conduct.& decr.card.output, ac.resp.distress.aft CV surg., poss.potent.
       Indications: Inotrop.support in treatm.of HF due to cardiomyopath.,   Indications: Convers.to sinus rhythm of paroxysmal supraventri-  of tox.eff.of O2  implicat., excess.dos.dur. maint.ther.relat.to excess.
       MI, card.surg.proced.         cul.tachycard.incl.those assoc.with access.by-pass tracts (WPW).  tiss. retent.of drug & /its metabolit., monit.pts.reg.for excess.dos.
       (S4) INFUS.CONC, 29/6.1/0345  (S4) INJ, 27/6.2/0467. 6 mg/2 ml  detect.& adjustm., reg.opthalm.exam. advis.dur.longt.ther., withdr.
       898697-006: 250 mg/20 ml vial, 1, R191,10  818259-019: 6 x2 ml vials, R1 147,58  if hyperthyroid. develop., sev.thyroid hyperactiv./hypofunct.can be
       898697-014: 250 mg/20 ml vial, 5, R955,49  Dosage: Use only in pres.of facilit.for card. monit. & resuscitat.   treat.with concom.suit.ther., monit.liv.funct.
       Dosage: Admin.by IV infus.as dil.sol. Usual rate: 2,5-10 µg/kg bm/  Pts.develop.high-lev. AV block at a particul.dos.should not be giv.  Drug interactions: Eff.of warfarin & other anticoags., clonazepam
       min.accord.to pt.heart rate, BP, card.& urine output. Range of 0,5 to   furth.dos.increm.  poss.enhanc., plasma conc of cyclosporin, digoxin, flecainide, phe-
       40 µg/kg/min. has been requir.  Adults: Init. 3 mg as rapid IV bolus (over 2 secs), 2nd dos: 6 mg as   nytoin, procainemide & quinidine poss.rais., phenytoin decr.plasma
       Contraindications: Mark.obstruct.of card.eject., safety in pregn./  rapid IV bolus if supraventric. tachycard. not elimin.within 1-2 mins.  conc., cimetidine & other inhibit.of metabol.enzymes incl.HIV prot.
       lactat./childr.not est., uncorrect. ventric. tachycard./ventric.fibrillat.  of 1st dos., 3rd dos: 12 mg as rapid IV bolus if supraventric. tachycard.  inhibit.incr.plasma conc., ß-block. & Ca-antagon.ther.potent., incr. risk
       Side effects: Hypertens., tachycard., ectop.beats, arrhythm. poss.  not elimin.within 1-2 mins.of 2nd dos. Addit./high. dos.not recomm.   of Torsade de Pointes with drugs which direct/ indirect.prolong QT
       precip., vasoconsctrict.esp.in pts. recent. treat.with ß-blocks., N&V,   No control.paed. study undertak.  interv.or agents induc. hypokalaem.
       headache, ang. pain, non-specif.chest pain, palpit., shortn.of breath,   Contraindications: 2nd/3rd degr.AV block & sick sinus syndr.except   Warnings: As eliminat.& absorpt.variable maint. dos.select.is diffic.
       incr.systol.BP, exagger.press.respons.in pts. with pre-exist.hyper-  in pts.with funct.artific. pacemaker., asthma, COPD, long QT syndr.,   requir.poss.dos.decr./discont., substitut.to other antiarrythm.diffic.as
       tens., incr.ventric.rate in pts. with pre-exist.atrial fibrillat., hypotens.,   sev. hypotens., decompens. HF states, safety & effic.in pregn.& lac-  amiodarone body burd.changes grad and unpredict.
       paraesthes., leg cramps.      tat.not est., concom. dipyridamole.
       Warnings and special precautions: Discont. grad., ac.MI esp.  Side effects: Hypotens., sev.bradycard., precip./ aggrav.bronchosp.,   BIO-AMIODARONE, Biotech [P/S]
       with widespread coron.artery dis., idiopath.hypertroph. subaort.  headache, dizzin., lightheadedn., rapid.revers.IC hypertens.worsen.,   Amiodarone HCl.
       stenos., poss. exacerb. pre-exist.tachycard./hypertens., pts.with ar-  psych.disords.incl.apprehens., blurr.vis., naus., metall.taste, sinus   Indications: Prevent.of tachyarrhythm.assoc. with WPW-syndr.&
       trial fibrillat.should be giv.card.glycosid.bef. treatm. reduc.enhanc.  pause, skipp.beat, atrial extrasystol., AV block, ventric.excitabil.dis-  other paroxysm. tachyarrhythm. incl.supraventric., nodal & ven-
       atrioventric.conduct.risk,dur. anaesthes. with halogen.anaesthet.,   ords. incl. torsade de pointes, sinus tachycard., palpitat., sev. brady-  tric. tachycard., atrial flutt.& fibrillat., ventric. fibrillat.when other
       1st correct. hypovolaem., reduc./discont.infus.if ser.ventric. arrhythm.   card.requir.tempor.pacing, atrial/ventric. fibrillat., dyspn., hyperven-  cannot be used.
       uncontr.by lignocaine or undue rise in sinus rate/syst.BP occurs, do   tilat., thorac.constrict. feel., chest pains/press., burn.sensat., sweat.,   (S4) TABS, 34/6.2/0119
       not add to 5% sod. bicarb. inj./any strong alkaline sol., agents/dilut.   discomf.feel., weakn., inj.site.reacts., loss of consciousn./syncope,   707851-001: 200 mg, 30, R297,09
       contain. sod.bisulphite & ethanol.  convuls., GI disturbs., asystole/card.arrest somet.fatal esp.in underly.   Dosage: Admin.minim.effect.dos.& manage accord.to pt.respons.&
       Drug interactions: Physic.incompat.with furosemide, hydrocor-  ischaem.heart dis., resp.fail./arrest, apnoea.  well being. Init: 200 mg 3xdly.x1 wk., then 200 mg 2xdly.x1 wk. Maint:
       tisone sod.succin., cefazolin, cefamandole nafate, sod.heparin,   Special precautions: (L) main coron.stenos., uncorrect.hypovol.,   200 mg dly.or less if appropr. Review regular.
       cephalothin, penicill., sod.bicarb., sod.erthacrynate, inotrop. effs.   stenot.valvul. heart dis., left to right shunt, pericardit./pericard.effus.,   Contraindications: Sinus bradycard./sino-atrial block& sinus dis.
       revers.by ß-block.            autonom. dysfunct./ stenot.carot.art.dis.with cerebrovasc. insuffic.,   without pacemak., ac. conduct. disturbs.without pacemak., hyperthy-
                                     recent MI/HF/pts.with min.conduct. defects that could be aggrav.dur.  roid., thyr. dysfunct., iodine sens., meds.produc.torsades de pointes,
       DOPAMINE HCl FRESENIUS 200 mg/5 ml AMPS, Fresenius   infus., pts.with atrial fibrillat./flutt.& an access.by-pass tract, poss.  sev.hypotens., class IA antiarrhythm./ sotalol/ stimul.laxat.& inj.
       Kabi [P/S]                    incr.conduct.down anomal.pathway, early post-heart transpl.pts., oc-  diltiazem, pregn.& breast feed., ac.porphyr., non-antiarrhythm. agents
       Dopamine HCl.                 cult sino-artrial dis., discont.ther.in case of ang./sev.bradycard./resp.   produc.torsades de pointes
       Indications: Shock unrespons.to fluid loss replacem.esp.in imp.ren.  fail./asyst./card.arrest, monit.convuls./seiz.hist., discont. dipyrida-  Side effects: Corneal microdepos., optic neuropathy with blurr.vis.,
       funct., correct.of haemodynam. imbal.assoc.with MI, trauma, sept.   mole 24 hrs bef.adenosine if concom.admin.essent., avoid concom.  decr.vis.acuity, photosens., skin pigmentat., hyper./hypothyroid., sev.
       shock & card.surg., chron.refract.CHF.                     pulm.toxic.incl.fibros.& interstit.pneumonit., revers. periph.neuropa-
       (S4) INFUS. Y/6.1/415.        aminophyll./ theophyll./ other xanthin.24 hrs bef.ther., avoid concom.  thy &/or myopathy, extra-pyramid. trem., cerebell.-like taxia, benign
       899027-007: 200 mg/5 ml, 10 amps, R590,30  food & drinks cont. xanthin.for at least 12 hrs prior to Adenocor.  IC hypertens., CNS effs., vertigo, cirrhos./hepatit., dose relat.brady-
                                     Drug interactions: Dipyridamole may potent. act., theophyll.&
       Dosage: IV infus.only. Must be dil.bef.admin.to conc.of 200 µg/ml   card., conduct.disturbs., sinus arrest, N&V, hypersens.reacts., ac.resp.
       by add.1 amp.of 200 mg/5 ml in 1 L of diluent.  other xanthines are strong adenosine inhibit., interacts with drugs   distress aft. CV surg.
       Init.rate: 2-5 µg/kg bm/min.grad.incr.by 5-10 µg/ kg/ min.accord.to   tend.to imp.card.conduct., high.degr.of heart block poss. in pres.  Special precautions: ECG prior to init.treatm., elderly, discont.if
       pts.BP, card.& urine output. Up to 20-50 µg/kg/min.in serious cases.  of carbamazepine.  2 /3  degr.AV block/sino-atrial/ bifascicul.block occur on treatm.,
                                                                   nd
                                                                     rd
       Contraindications: Phaeochromocyt., MAOI’s, uncorrect. tach-  ARYCOR, Winthrop [P/S]  monit. thyr. & liv.funct.reg., reg.opthalm.examin., avoid sunlight
       yarrhythm./ventr.fibrillat., safety in childr./pregn.& lactat.not est.  Amiodarone HCl.  expos., withdr.in case of hyperthyroid., monit. pulm.funct.on long
       Side effects: CNS eff., headache, GI disturbs., complex CV eff.,   Indications: Prevent.of tachyarrhythm.assoc. with WPW-syndr.&   term treatm., electrol. disturbs. esp.hypokalaem., mod.to sev.ren.
       diffic.micturit., urin.retent., dyspn., alter.metab., sweat., hypersali-  other types of tachyarrhthm.of paroxysmal nature incl.supraventric.,   impairm., gen.anaesth.
       vat., piloerect.              nodal & ventric. tachycard., atrial flutter & fibrillat., ventric. fibrillat.  Drug interactions: ß-block.& some Ca chan. block. (verapamil &
       Special precautions: Concom.halog.anaesth., always infus.into   when other drugs cannot be used.  diltiazem) potent.bradycard./ sin. arrest & AV block results, drugs
       large lumen vein to avoid tiss. necros., correct hypovol.fully bef.  (S4) TABS, 32/6.2/0513, 0514  incr.torsade de pointes risk or agents induc.hypokalaem., oral anti-
       admin., reduct.in urin. flow without hypotens.may indic.dos.reduct.,   703515-001: 100 mg, 30, R263,60  coags. eff.incr., digox.plasma conc.rais., phenytoin plasma conc.incr.
       diab. mellit., clos.angle glauc., grad.discont.avoid undue hypotens.  703513-001: 200 mg, 30, R460,41
       assoc.with very low dos.where vasodilat. predomin.  Dosage: Use only in life-threaten.arrhythm.as use is accompan.by   CORDARONE X, Sanofi-Aventis [P/S]
       Drug interactions: MAOI prolongs & potent.eff., TCA’s, ß-blocks.,   substant.toxic. Utilise altern. agents first as life-threat.probl.poss    Amiodarone HCl.
       ergot derivat., IV phenytoin, digit. glycosid.  As absorpt.& eliminat.are variab.maint.dos.select.diffic. Hospitalis.  Indications: Prevent.of tachyarrhythm.assoc. with WPW-syndr.&
       Warnings: Vasc.collapse with abrupt discontin., do not add to 5%   while load.dos.giv. Admin.minim.effect. dos. Pt.managem.must be   other types of tachyarrhythm.of paroxysmal nature incl.supraven-
       Na Bic.or any alkaline IV sol.  judg.on indiv.respons.& well being. Use 100 mg scored tab.to titrate   tric., nodal & ventric. tachyarrhythm., atrial flutter & fibrillat., ventric.
                                                                  fibrillat.when other meds. cannot be used
       PHARMA-Q DOPAMINE INJECTION 200 mg/5 ml,    min. dos. Init.oral ther.ASAP aft.adeq.respon.obt.from IV ther.which   (S4) TABS, [P/S] P/6.2/165
       Pharma-Q [P/S]                should then be grad.phas.out.  716111-004: 200 mg, 30, R798,03
       Dopamine HCl.                 Indiv. Init: 200 mg 3xdly.for 1 wk., then 200 mg 2xdly.for 1 wk.   Dosage: Use only in life-threaten.arrhythm.as use is accompan.by
       Indications: Shock unrespons.to fluid loss replacem.esp.in imp.  Maint.200 mg dly. Review.reg.to detect clinic.excess dos.esp.if   substant.toxic. Utilize altern. agents first as life-threat.probl.poss. Hos-
       ren.funct., haemodynam. imbal. assoc.with MI/trauma/sept.shock   exceed.200 mg dly.  pitalis. while load.dos.giv. As absorpt.& eliminat.are variab. maint.
       & card. surg., CHF.           Contraindications: Sinus bradycard., sino-atrial heartblock, sev.  dos.select.diffic. Admin.minim. effect. dos. Use 100 mg scored tab.
       (S4) INJ.CONC. 30/6.1/0169.   conduct.disturbs.or sinus node dis. (unless in conjunct.with pace-  to titrate min. dos. Init.oral ther.ASAP aft.adeq.respon.obt.from IV
       704945-001: 200 mg/5 ml, 10 amps, R416,51  maker), thyroid dysfunct., I-hypersens.for 200 mg tabs., CHF, breast-  ther.which should then be grad.phas.out.
       Dosage: IV infus.only. Must be dilut.only in Dextr. 5% &/or 0,9%   feed., pregn., safety & effic.in paeds.not est., sunlight expos., por-  Indiv. Init: 200 mg 3xdly. for 1 wk., then 200 mg 2xdly.for 1 wk.
       NaCl infus.sol.               phyr., concom.class1a anti-arrhythmogen.meds.bepridil & sotalol.  Maint.200 mg dly. Review.reg.to detect clinic.excess dos.esp.if
       Add 1 amp.of 200 mg/5 ml.to 1 L diluent to obtain conc.of 200 µg/ml  Side effects: Potent.fatal toxic.esp.pulm.toxic., liv.injury/disords., ar-  exceed.200 mg dly.
       Init.rate: 2-5 µg/kg bm/min.grad.incr.by 5-10 µg/kg / min.accord.to   rhythm.poss.exacerbat., heartblock/sinus bradycard., corneal micro-  (S4) INJ, [P/S] S/6.2/384. 150 mg/3 ml
       pt.BP/card.& urine output. Up to 20-50 µg/kg/min.may be requir.in   depos. (cont. ther.), haemolyt.anaem., thrombocytopen., bradycard.,   Indications: Where rapid respons.reqd.to control tachyarrhythm.
       serious.ill pts. High.dos.have been giv.  ECG chang., new arrhythm./worsen.of exist.arrhythm.sometim.foll.  assoc.with WPW-syndr.& other types of tachyarrhythm. of paroxys-
       Contraindications: Phaeochromocyt., tachyarrhythm., ventr.arrhythm.  by CA, conduct. disturbs., sinus arrest, hyper/hypothyroid., opthalm.   mal nature incl.supraventric., nodal & ventric.tachyarrhythm., atrial
       Side effects: CNS eff., trem., weakn., GI disturbs., compl.CV effs.  abnormalit.incl.optic neuropathy, photosens. & other skin reacts.,   flutter & fibrillat., ventric.fibrillat.resist.to other antiarrhythm.ther.,
       incl.hypertens.poss. produc. cerebr.haemorrh./pulm.oed., reflex brady-  N&V, metall.taste, incr.in ser.transamin., ac./chron.liv.dis.dur.longt   cardiopulm.resus.in adult card.arrest caus.by ventric.fibrillat.resist.
       card., tachycard., arrhythm., ang.pain, palpitat., card.arrest, poss.hy-  ther., sometimes fatal.cholestas.with jaund., incr. in bld.creatinine,   to extern. electr.shock
       potens.with dizzin./ faint./ flush., diffic.micturit., urin.retent., dyspn.,   CNS effs., trem., periph. neuropathy &/myopathy, atax., benign IC-hy-  716162-009: 6x3 ml, R651,22</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page123.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page119.html">119</a>&nbsp;&nbsp;&nbsp;<a href="page120.html">120</a>&nbsp;&nbsp;&nbsp;<a href="page121.html">121</a>&nbsp;&nbsp;&nbsp;<a href="page122.html">122</a>&nbsp;&nbsp;&nbsp;<a href="page123.html">123</a>&nbsp;&nbsp;&nbsp;<a href="page124.html">124</a>&nbsp;&nbsp;&nbsp;<a href="page125.html">125</a>&nbsp;&nbsp;&nbsp;<a href="page126.html">126</a>&nbsp;&nbsp;&nbsp;<a href="page127.html">127</a>&nbsp;&nbsp;&nbsp;<a href="page128.html">128</a>&nbsp;&nbsp;&nbsp;<a href="page129.html">129</a>
             </td>
             <td width="35%"><a href="page125.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page125.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
